[hayst4ck]

1.08 in 100,000 cases of vaccine related myocarditis (VRM), 2.16 deaths per 1,000,000.

Hard to take much meaning away from that without understanding the risk posed by not vaccinating.

If vaccines can prevent long COVID or "post viral syndrome," that's another potential cost benefit analysis. (which would make sense from a laymen perspective, killing k random cells seems bad, but killing N random cells seems strictly worse).

[tpoacher]

This is true, but misses an important exception: people who received vaccines despite demonstrating natural immunity at the time of vaccination.

Indeed I'd be interested to know of those episodes of VRM, how many of them had recent COVID, and whether these individuals had worse outcomes. I suspect you'd find these individuals were put at increased risk, for no clear increase in benefit.

[oldgradstudent]

> Hard to take much meaning away from that without understanding the risk posed by not vaccinating.

What's the benefit from vaccinating otherwise healthy young men against Covid? Not people in risk groups, but healthy young men.

It should be obvious that if your clinical trials cannot rule out major adverse events in 1 in N, you shouldn't vaccinate populations in which the benefit occurs in less than 1 in N.

> If vaccines can prevent long COVID or "post viral syndrome, that's another potential cost benefit analysis.

That's a big "If".